The European Medicines Agency (EMA) will announce its analysis of the link between the AstraZeneca vaccine and blood clot formation at 4 pm today.
The conclusion will be announced at a press conference, and you can follow it in real time on Twitter.
EMA’s conclusions are particularly important for Croatia, because our country has ordered the most vaccines from AstraZeneca.
Recall that the senior EMA official in charge of vaccine strategy told the Italian newspaper Il Messaggero yesterday that there is a link between AstraZeneca and the formation of rare blood clots.
He said: “I think it can now be said that it is obviously related to the vaccine. However, we still don’t know what caused this reaction.”
Cavalieri concluded: “There are more cases of cerebral thrombosis among vaccinated people. Among young people, this has exceeded our expectations. We have to say that.”
CNIPH director and member of the National Civil Defense Headquarters Krunoslav Capak also commented on Cavaleri’s statement yesterday. He said that our headquarters is waiting for EMA’s evaluation and then may make new recommendations.
“This information resonates incredibly in Croatia. I will not comment on this, I will wait for the EMA to evaluate. We have considered all the cases. We believe that AstraZeneca’s benefits still outweigh the risks, but we Will see what EMA will say and we are ready to make new recommendations. If needed,” he said.
When asked whether the EMA still considers AstraZeneca to be unsafe, Capak said: “I don’t think there will be a suspension of vaccines, which is unlikely. But regulatory recommendations for certain populations are possible. We have not yet agreed with Like everyone else, if they don’t mind using AstraZenec for vaccination, they can take another dose or continue to take another dose, which is also very effective. I don’t think this will be a problem.”